Innovative Formulation Strategies for Biosimilars: Trends Focused on Buffer-Free Systems, Safety, Regulatory Alignment, and Intellectual Property Challenges. [PDF]
Pharmaceuticals (Basel)Bas TG.
europepmc +1 more source
Biosimilars – Global issues, national solutions
, 2011 Ivana Knežević, Elwyn Griffiths
openalex +1 more source
Biosimilars and non-innovator biotherapeutics in India: An overview of the current situation
, 2011 Hemant Malhotra
openalex +1 more source
Austria increases dialogue in order to involve physicians more with biosimilars [PDF]
, 2012 Christoph Baumgärtel
openalex +1 more source
Evaluation of Methods Employed in Establishing Preclinical Similarity of Adalimumab Biosimilars. [PDF]
Adv Pharmacol Pharm SciNair R +3 more
europepmc +1 more source
Beyond cost: a value-based framework for biosimilar procurement in emerging markets - the Thai experience. [PDF]
J Pharm Policy PractAssawamakin A +3 more
europepmc +1 more source
Associate Editor’s Commentary: The Tao of Biosimilars [PDF]
, 2012 Peter J. Pitts
openalex +1 more source
Scientific Justification and Policy Recommendations to the US Food and Drug Administration for Waiving Comparative Efficacy Studies. [PDF]
Pharmaceuticals (Basel)Niazi SK.
europepmc +1 more source